These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3275843)

  • 1. Rheumatoid arthritis: can the long-term outcome be altered?
    Gabriel SE; Luthra HS
    Mayo Clin Proc; 1988 Jan; 63(1):58-68. PubMed ID: 3275843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
    Wolfe F; Hawley DJ; Cathey MA
    J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical treatment of rheumatoid arthritis].
    Isomäki H; Martio J
    Duodecim; 1976; 92(6):304-12. PubMed ID: 816634
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489
    [No Abstract]   [Full Text] [Related]  

  • 5. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects?
    Scott DL; Greenwood A; Davies J; Maddison PJ; Maddison MC; Hall ND
    Br J Rheumatol; 1990 Apr; 29(2):126-7. PubMed ID: 2182170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis.
    Pugh MC; Pugh CB
    Clin Pharm; 1987 Jun; 6(6):475-91. PubMed ID: 3319362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
    Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy in the rheumatic diseases.
    Reardon EV; Clough JD
    Compr Ther; 1992 Nov; 18(11):22-5. PubMed ID: 1478055
    [No Abstract]   [Full Text] [Related]  

  • 11. [The basic treatment of rheumatoid arthritis. Current trends].
    Suţeanu S; Manuchian M
    Med Interne; 1984; 22(4):241-51. PubMed ID: 6393302
    [No Abstract]   [Full Text] [Related]  

  • 12. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study.
    Scott DL; Dawes PT; Tunn E; Fowler PD; Shadforth MF; Fisher J; Clarke S; Collins M; Jones P; Popert AJ
    Br J Rheumatol; 1989 Apr; 28(2):128-33. PubMed ID: 2650798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
    Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
    Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment of progressive rheumatoid arthritis.
    Champion GD; Richter MB
    Ann Acad Med Singap; 1991 Jan; 20(1):127-32. PubMed ID: 2029152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO; Ward JR
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early, aggressive therapy for rheumatoid arthritis: concerns, descriptions, and estimate of outcome.
    Wilke WS; Sweeney TJ; Calabrese LH
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):26-41. PubMed ID: 8278817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term radiographic progression in treated rheumatoid arthritis.
    van der Heijde DM; van Riel PL; van de Putte LB
    Br J Rheumatol; 1990 Oct; 29(5):404. PubMed ID: 1977489
    [No Abstract]   [Full Text] [Related]  

  • 19. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Pincus T; Callahan LF
    Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis.
    van der Heide A; Jacobs JW; Schenk Y; Bijlsma JW
    J Rheumatol; 1994 Dec; 21(12):2195-9. PubMed ID: 7699618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.